If you made investments in exchange-traded funds focused on gold and bet against those pegged to biotechnology, you would have made a pretty penny in the first quarter of 2016.
read more
If you made investments in exchange-traded funds focused on gold and bet against those pegged to biotechnology, you would have made a pretty penny in the first quarter of 2016.
read more